Search Results
Found 1 results
510(k) Data Aggregation
(41 days)
ALKPHASE-B ASSAY KIT
Measurement of BAP is intended for use as an aid in the:
management of postmenopausal osteoporosis and Paget's disease.
monitoring of postmenopausal women on hormonal or bisphosphonate therapy
prediction of skeletal response to hormonal therapy in postmenopausal women.
Not Found
I am sorry, but the provided text from the FDA 510(k) letter for the Alkphase-B® Assay Kit does not contain information about the acceptance criteria, study details, sample sizes, expert qualifications, or ground truth establishment. The document is an FDA letter granting substantial equivalence, not a detailed study report. Therefore, I cannot generate the requested table and paragraphs based on this input.
Ask a specific question about this device
Page 1 of 1